🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Turkey / NCT07583693
Starting soon Not applicable

HBM-Based Intervention on Cancer Screening

NCT07583693 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-05-06
Last updated
2026-05-13

Condition(s) studied

Cancer ScreeningHealth Belief ModelAttitudePerception

Investigational drug(s) / intervention(s)

HBM-Based İntervention on Cancer Screening

HBM-Based İntervention on Cancer Screening: The intervention group will receive a single-session group education lasting 45 minutes. The educational session will be supported by visual presentations, demonstrations on anatomical models, question-and-answer sessions, and group discussions. The curriculum covers the importance of early diagnosis and specific screening methods for breast, cervical, and colorectal cancers. Following the session, participants will receive motivational SMS reminders once a week for two consecutive weeks. These text messages will include motivational phrases to encourage screening attendance, as well as phone numbers and links for scheduling free screening appointments.

Study summary

The aim of this study is to examine the effect of an intervention-consisting of a Health Belief Model-based educational session on the importance of early diagnosis and cancer screening, along with SMS-supported reminders-on the perceptions and attitudes toward cancer screening among women aged 30-70 who do not undergo regular screenings. The study will be conducted in two family centers, which will be assigned to intervention and control groups using a lottery method. The intervention group will receive a single-session group education, followed by weekly SMS reminders encouraging screening for two weeks. The control group will receive no additional intervention and will continue with standard care. Data will be collected simultaneously from both groups at three points: before the education, immediately after the education, and one month post-intervention.

Eligibility

Sex
FEMALE
Min age
30 Years
Max age
70 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Being female * Being between the ages of 30 and 70 * Being able to communicate in Turkish * Not having undergone regular cancer screenings Exclusion Criteria: * Having a previous diagnosis of any type of cancer * Being under medical follow-up for suspected cancer * Having cognitive impairment that prevents effective communication

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Lokman Hekim Universty Ankara Ankara

More Lokman Hekim University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07583693 on ClinicalTrials.gov ↗ ← All trials in Turkey